MAPS Act

This bill requires the Food and Drug Administration (FDA) to keep an updated list of medicines that are considered essential and always need to be available, including drugs needed during public health emergencies and those at high risk of running short. The FDA must review this list at least every two years and study the supply chains for these medicines to find potential problems, like drugs that come from only one supplier or are mostly made in other countries, and report its findings to Congress every year. The Department of Health and Human Services must also track and monitor these supply chains to spot weaknesses and share information across government agencies about where and how much of these medicines are being produced.

Your Vote